Equities

Bioceres Crop Solutions Corp

Bioceres Crop Solutions Corp

Actions
Basic MaterialsChemicals
  • Price (USD)6.13
  • Today's Change-0.31 / -4.81%
  • Shares traded218.65k
  • 1 Year change-48.83%
  • Beta0.4957
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform4
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 5 analysts offering 12 month price targets for Bioceres Crop Solutions Corp have a median target of 13.00, with a high estimate of 19.00 and a low estimate of 9.50. The median estimate represents a 101.86% increase from the last price of 6.44.
High195.0%19.00
Med101.9%13.00
Low47.5%9.50

Earnings history & estimates in USD

On Nov 11, 2024, Bioceres Crop Solutions Corp reported 1st quarter 2025 losses of -0.09 per share.
The next earnings announcement is expected on Feb 10, 2025.
Average growth rate+218.42%
Bioceres Crop Solutions Corp reported annual 2024 earnings of 0.05 per share on Sep 09, 2024.
Average growth rate-24.10%
More ▼

Revenue history & estimates in USD

Bioceres Crop Solutions Corp. had 1st quarter 2025 revenues of 92.60m. This missed the 109.25m consensus estimate of the 4 analysts following the company. This was 20.58% below the prior year's 1st quarter results.
Average growth rate+0.61%
Bioceres Crop Solutions Corp. had revenues for the full year 2024 of 464.80m. This was 10.72% above the prior year's results.
Average growth rate+29.24%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.